Therapeutic breakthroughs in medicine are usually accompanied by a
wealth of data. Often they result in a change of disease treatment
paradigms. Tacrolimus ointment is the first in the new class of
steroid-free Topical Immunomodulators (TIMs), and as such
represents the first true breakthrough since the introduction of
topical steroids more than 50 years ago for the treatment of T-cell
mediated inflammatory skin diseases such as atopic dermatitis. This
book gives an easy-to-read overview of the discovery and the
development of Tacrolimus ointment for the treatment of atopic
dermatitis. Summarising the largest clinical trial program ever
conducted in dermatology for a new treatment with more than 13000
patients, it offers a detailed insight into the efficacy and safety
profile of Tacrolimus ointment. Based on this large body of data
and extensive personal experience, the authors offer practical and
hands-on guidance for the physician as to when and how to use
Tacrolimus ointment in daily practice.
General
Imprint: |
Springer-Verlag
|
Country of origin: |
Germany |
Release date: |
August 2014 |
First published: |
2004 |
Editors: |
T. Ruzicka
• S. Reitamo
|
Dimensions: |
254 x 203 x 22mm (L x W x T) |
Format: |
Paperback
|
Pages: |
279 |
Edition: |
Softcover reprint of the original 1st ed. 2004 |
ISBN-13: |
978-3-662-10211-4 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
Dermatology
|
LSN: |
3-662-10211-0 |
Barcode: |
9783662102114 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!